Safety of Ustekinumab With and Without Concomitant Corticosteroids or Immunosuppressants in Patients With Moderately to Severely Active Crohnʼs Disease

Authors :: Ghosh Subrata
Sands Bruce
Lang Yinghua
Ott Elyssa
Jacobstein Douglas
Ramachandran Paraneedharan
Gasink Christopher
Source :: American Journal of Gastroenterology. 112:S329-S330
Publication Year :: 2017
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2017.

Subjects :: medicine.medical_specialty
Hepatology
business.industry
Concomitant
Internal medicine
Ustekinumab
Gastroenterology
Medicine
In patient
Disease
business
medicine.drug

Tools